50884 Federal Register / Vol. 86, No. 174 / Monday, September 13, 2021 / Notices 

boundaries, in the first untitled table 

that begins with ‘‘Waterbody Limits’’ 

column, which appears on pages 25856 

through 25857, is corrected to read as 

follows: 

Waterbody Waterbody/Limits Area (acres) 

Stony Creek .............................................. 39.1723° N, 76.5171° W to 39.1725° N, 76.5126° W ................................................. 677 

Rock Creek ............................................... 39.1614° N, 76.5004° W to 39.1625° N, 76.4862° W ................................................. 524 

South Shore, Patapsco River ................... 39.1472° N, 76.4589° W to 39.1471° N, 76.4588° W ................................................. 2 

Bodkin Creek ............................................ 39.1346° N, 76.4398° W to 39.1320° N, 76.4384° W ................................................. 609 

Magothy and Little Magothy Rivers .......... 39.0592° N, 76.4332° W to 39.0462° N, 76.4295° W ................................................. 5,879 

Podickory Creek ....................................... 39.0328° N, 76.4040° W to 39.0318° N, 76.4049° W ................................................. 9 

Sandy Point/Mezick Ponds ....................... 39.0087° N, 76.4032° W to 39.0086° N, 76.4037° W ................................................. 47 

Whitehall Bay ............................................ 38.9748° N, 76.4547° W to 38.9871° N, 76.4268° W ................................................. 1,599 

Severn River ............................................. 38.9747° N, 76.4547° W to 38.9411° N, 76.4504° W ................................................. 7,497 

Oyster Creek ............................................. 38.9274° N, 76.4638° W to 38.9273° N, 76.4634° W ................................................. 34 

Fishing Creek ............................................ 38.9148° N, 76.4591° W to 38.9073° N, 76.4602° W ................................................. 228 

South River ............................................... 38.9073° N, 76.4602° W to 38.8850° N, 76.4910° W ................................................. 5,904 

West and Rhode Rivers ........................... 38.8850° N, 76.4910° W to 38.8531° N, 76.4959° W ................................................. 4,370 

Total Area .......................................... ....................................................................................................................................... 27,379 

Dated: September 2, 2021. 

Diana Esher, 

Acting Regional Administrator, EPA Region 

III. 

[FR Doc. 2021–19601 Filed 9–10–21; 8:45 am] 

BILLING CODE 6560–50–P 

EXPORT-IMPORT BANK 

[Public Notice 2021–3027] 

Agency Information Collection 

Activities: Comment Request 

AGENCY: Export-Import Bank of the 

United States. 

ACTION: Submission for OMB review and 

comments request. 

SUMMARY: The Export-Import Bank of 

the United States (EXIM), as a part of its 

continuing effort to reduce paperwork 

and respondent burden, invites the 

general public and other Federal 

Agencies to comment on the proposed 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

DATES: Comments must be received on 

or before October 13, 2021 to be assured 

of consideration. 

ADDRESSES: Comments may be 

submitted electronically on 

WWW.REGULATIONS.GOV or by mail 

to Edward Coppola, Export-Import Bank 

of the United States, 811 Vermont Ave. 

NW, Washington, DC 20571. 

The form can be viewed at: https://

www.exim.gov/sites/default/files/pub/ 

pending/eib11-04.pdf. 

FOR FURTHER INFORMATION CONTACT: To 

request additional information, please 

Edward Coppola Edward.Coppola@

exim.gov. 202–565–3717. 

Form can be viewed at https://

www.exim.gov/sites/default/files/pub/ 

pending/eib92-79.pdf. 

SUPPLEMENTARY INFORMATION: 

Title and Form Number: EIB 92–79 

Broker Registration Form. 

Form Title: EIB 92–79 Broker 

Registration Form. 

OMB Number: 3048–0024. 

Type of Review: Regular. 

Need and Use: This form is used by 

insurance brokers to register with 

Export Import Bank. The form provides 

Export Import Bank staff with the 

information necessary to make a 

determination of the eligibility of the 

broker to receive commission payments 

under Export Import Bank’s credit 

insurance programs. 

Our customers will be able to submit 

this form on paper or electronically. 

This form is used by insurance brokers 

to register with Export-Import Bank. It 

provides EXIM staff with the 

information necessary to make a 

determination of the eligibility of the 

broker to receive commission payments 

under Export-Import Bank’s credit 

insurance programs. 

Affected Public: This form affects 

entities engaged in brokering export 

credit insurance policies. 

Annual Number of Respondents: 50. 

Estimated Time per Respondent: 15 

minutes. 

Frequency of Reporting or Use: Once 

every three years. 

Government Expenses: 

Review Time per Response: 2 hours. 

Reviewing Time per Year: 100 hours. 

Average Wages per Hour: $42.50. 

Average Cost per Year: $4,250. 

Benefits and Overhead: 20%. 

Total Government Cost: $5,100. 

Bassam Doughman, 

IT Specialist. 

[FR Doc. 2021–19633 Filed 9–10–21; 8:45 am] 

BILLING CODE 6690–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–R–308] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), Federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by October 13, 2021. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 174 / Monday, September 13, 2021 / Notices 50885 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at 

website address at: https://

www.cms.gov/Regulations-andGuidance/Legislation/Paperwork

ReductionActof1995/PRA-Listing.html. 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: State Children’s 

Health Insurance Program and 

Supporting Regulations; Use: States 

must submit title XXI plans and 

amendments for approval by the 

Secretary. We use the plan and its 

subsequent amendments to determine if 

the state has met the requirements of 

title XXI. Information provided in the 

state plan, state plan amendments, and 

from the other information we are 

collecting will be used by advocacy 

groups, beneficiaries, applicants, other 

governmental agencies, providers 

groups, research organizations, health 

care corporations, health care 

consultants. States will use the 

information collected to assess state 

plan performance, health outcomes and 

an evaluation of the amount of 

substitution of private coverage that 

occurs as a result of the subsidies and 

the effect of the subsidies on access to 

coverage. 

This iteration proposes to: Remove 

certain reporting requirements, revise 

the information collection instrument, 

and revise reporting instructions. We 

are also proposing to change the 

respondent’s occupation and hourly 

wage, adjust the number of respondents, 

and adjust the number of enrollees by 

using more recent data. Form Number: 

CMS–R–308 (OMB control number: 

0938–0841); Frequency: Yearly, Once, 

and Occasionally; Affected Public: State, 

Local, or Tribal Governments; Number 

of Respondents: 51; Total Annual 

Responses: 9,677,272; Total Annual 

Hours: 485,940. (For policy questions 

regarding this collection contact Cassie 

Lagorio at 410–786–4554.) 

Dated: September 7, 2021. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2021–19599 Filed 9–10–21; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2021–N–0008] 

Blood Products Advisory Committee; 

Notice of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA or Agency) 

announces a forthcoming public 

advisory committee meeting of the 

Blood Products Advisory Committee. 

The general function of the committee is 

to provide advice and recommendations 

to the Agency on FDA’s regulatory 

issues. Members will participate via 

teleconference. At least one portion of 

the meeting will be closed to the public. 

DATES: The meeting will be held on 

November 4, 2021, from 9:30 a.m. to 

5:20 p.m. Eastern Time. 

ADDRESSES: Please note that due to the 

impact of the COVID–19 pandemic, all 

meeting participants will be joining this 

advisory committee meeting via an 

online teleconferencing platform. The 

online web conference meeting will be 

available at the following link on the 

day of the meeting: https://youtu.be/ 

2Xz4YzkwNDs. 

FOR FURTHER INFORMATION CONTACT: 

Christina Vert or Joanne Lipkind, Center 

for Biologics Evaluation and Research, 

Food and Drug Administration, 10903 

New Hampshire Ave., Bldg. 71, Rm. 

6268, Silver Spring, MD 20993–0002, 

240–402–8054, Christina.Vert@

fda.hhs.gov, or 240–402–8106, 

Joanne.Lipkind@fda.hhs.gov, 

respectively, or FDA Advisory 

Committee Information Line, 1–800– 

741–8138 (301–443–0572 in the 

Washington, DC area). A notice in the 

Federal Register about last minute 

modifications that impact a previously 

announced advisory committee meeting 

cannot always be published quickly 

enough to provide timely notice. 

Therefore, you should always check the 

Agency’s website at https://

www.fda.gov/AdvisoryCommittees/ 

default.htm and scroll down to the 

appropriate advisory committee meeting 

link, or call the advisory committee 

information line to learn about possible 

modifications before coming to the 

meeting. 

SUPPLEMENTARY INFORMATION: 

Agenda: The meeting presentations 

will be heard, viewed, captioned, and 

recorded through an online 

teleconferencing platform. On 

November 4, 2021, for Topic I, the 

committee will meet in open session to 

hear an overview of the research 

programs of the Plasma Derivatives 

Branch, Division of Plasma Protein 

Therapeutics, Office of Tissues and 

Advanced Therapies, Center for 

Biologics Evaluation and Research 

(CBER). For Topic II, the committee will 

meet in open session to hear an 

overview of the research programs of the 

Laboratory of Cellular Hematology, 

Division of Blood Components and 

Devices, Office of Blood Research and 

Review (OBRR), CBER. For Topic III, the 

committee will meet in open session to 

hear an overview of the research 

programs of the Laboratory of Emerging 

Pathogens, Division of Emerging & 

Transfusion Transmitted Diseases, 

OBRR, CBER. After the open sessions, 

the meeting will be closed to the public 

for committee deliberations. 

FDA intends to make background 

material available to the public no later 

than 2 business days before the meeting. 

If FDA is unable to post the background 

material on its website prior to the 

meeting, the background material will 

be made publicly available at the 

location of the advisory committee 

meeting, and the background material 

will be posted on FDA’s website after 

the meeting. Background material is 


lotter on DSK11XQN23PROD with NOTICES1